Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Iro, Heinrich
2009.
Handbuch HNO 2009.
p.
355.
Knecht, Rainald
2009.
Handbuch HNO 2009.
p.
311.
Grünbaum, M.
Ervens, J.
Stein, H.
and
Loddenkemper, C.
2010.
Primäres duktales Adenokarzinom im Bereich der Orbita.
Der Pathologe,
Vol. 31,
Issue. 4,
p.
279.
Sharon, Elad
Kelly, Ronan J
and
Szabo, Eva
2010.
Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine.
Head & Neck Oncology,
Vol. 2,
Issue. 1,
Clauditz, Till Sebastian
Reiff, Maren
Gravert, Linn
Gnoss, Alexander
Tsourlakis, Maria-Christina
Münscher, Adrian
Sauter, Guido
Bokemeyer, Carsten
Knecht, Rainald
and
Wilczak, Waldemar
2011.
Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
Pathology,
Vol. 43,
Issue. 5,
p.
459.
Suzuki, Takayoshi
Kano, Satoshi
Oridate, Nobuhiko
Honma, Akihiro
Suzuki, Seigo
Hatakeyama, Hiromitsu
Mizumachi, Takatsugu
Furusawa, Jun
Sakashita, Tomohiro
and
Fukuda, Satoshi
2011.
HER2 expression in salivary duct carcinoma.
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY,
Vol. 21,
Issue. 2,
p.
195.
Taniguchi, Zenchi
Iguchi, Fukuichiro
Takahashi, Yuka
and
Murai, Norihiko
2011.
A Case of Parotid Gland Salivary Duct Carcinoma with HER-2 Protein Overexpression.
Practica Oto-Rhino-Laryngologica,
Vol. 104,
Issue. 1,
p.
33.
Jaspers, Heidy C.J.
Verbist, Berit M.
Schoffelen, Rafke
Mattijssen, Vera
Slootweg, Piet J.
van der Graaf, Winette T.A.
and
van Herpen, Carla M.L.
2011.
Androgen Receptor–Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options.
Journal of Clinical Oncology,
Vol. 29,
Issue. 16,
p.
e473.
Lagha, Aymen
Chraiet, Nesrine
Ayadi, Mouna
Krimi, Sarra
Allani, Bassem
Rifi, Hela
Raies, Henda
and
Mezlini, Amel
2012.
RETRACTED: Systemic therapy in the management of metastatic or advanced salivary gland cancers.
Oral Oncology,
Vol. 48,
Issue. 10,
p.
948.
Hashimoto, Kazuki
Yamamoto, Hidetaka
Shiratsuchi, Hideki
Nakashima, Torahiko
Tamiya, Sadafumi
Nishiyama, Ken‐ichi
Higaki, Yuichiro
Komune, Shizuo
Tsuneyoshi, Masazumi
and
Oda, Yoshinao
2012.
HER‐2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in‐situ hybridization study.
Histopathology,
Vol. 60,
Issue. 6B,
Kim, J Y
Lee, S
Cho, K-J
Kim, S Y
Nam, S Y
Choi, S-H
Roh, J-L
Choi, E K
Kim, J H
Song, S Y
Shin, H S
Chang, S-K
and
Ahn, S D
2012.
Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands.
The British Journal of Radiology,
Vol. 85,
Issue. 1018,
p.
e947.
Hiwatashi, Nao
Takebayashi, Shinji
Suzuki, Chiaki
Miyoshi, Takushi
Ikeda, Hiroki
and
Miura, Makoto
2012.
Salivary duct carcinoma in the submandibular gland with HER-2 protein overexpression: A report of two cases.
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY,
Vol. 22,
Issue. 3,
p.
327.
Lagha, Aymen
Chraiet, Nesrine
Ayadi, Mouna
Krimi, Sarra
Allani, Bassem
Rifi, Hela
Raies, Henda
and
Mezlini, Amel
2012.
Systemic therapy in the management of metastatic or advanced salivary gland cancers.
Head & Neck Oncology,
Vol. 4,
Issue. 1,
Wee, D T H
Thomas, A A
and
Bradley, P J
2012.
Salivary duct carcinoma: what is already known, and can we improve survival?.
The Journal of Laryngology & Otology,
Vol. 126,
Issue. S2,
p.
S2.
Krishnamurthy, Jairam
Krishnamurty, Devi Mukkai
Baker, John J.
Zhen, Weining
Lydiatt, Daniel
and
Ganti, Apar Kishor
2013.
Salivary duct carcinoma responding to trastuzumab‐based therapy: Case report and review of the literature.
Head & Neck,
Vol. 35,
Issue. 12,
Griffith, Christopher C.
Seethala, Raja R.
Luvison, Alyssa
Miller, Megan
and
Chiosea, Simion I.
2013.
PIK3CA Mutations and PTEN Loss in Salivary Duct Carcinomas.
American Journal of Surgical Pathology,
Vol. 37,
Issue. 8,
p.
1201.
Limaye, Sewanti A.
Posner, Marshall R.
Krane, Jeffrey F.
Fonfria, Maria
Lorch, Jochen H.
Dillon, Deborah A.
Shreenivas, Aditya V.
Tishler, Roy B.
and
Haddad, Robert I.
2013.
Trastuzumab for the Treatment of Salivary Duct Carcinoma.
The Oncologist,
Vol. 18,
Issue. 3,
p.
294.
Kadowaki, Shigenori
Yatabe, Yasushi
Hirakawa, Hitoshi
Komori, Azusa
Kondoh, Chihiro
Hasegawa, Yasuhisa
and
Muro, Kei
2013.
Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.
Case Reports in Oncology,
Vol. 6,
Issue. 3,
p.
450.
Nardi, Valentina
Sadow, Peter M.
Juric, Dejan
Zhao, Dave
Cosper, Arjola K.
Bergethon, Kristin
Scialabba, Vanessa L.
Batten, Julie M.
Borger, Darrell R.
Iafrate, Anthony John
Heist, Rebecca S.
Lawrence, Donald P.
Flaherty, Keith T.
Bendell, Johanna C.
Deschler, Daniel
Li, Yi
Wirth, Lori J.
and
Dias-Santagata, Dora
2013.
Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment.
Clinical Cancer Research,
Vol. 19,
Issue. 2,
p.
480.
Zhang, Li
Mitani, Yoshitsugu
Caulin, Carlos
Rao, Pulivarthi H.
Kies, Merrill S.
Saintigny, Pierre
Zhang, Nianxiang
Weber, Randal S.
Lippman, Scott M.
and
El-Naggar, Adel K.
2013.
Detailed Genome-Wide SNP Analysis of Major Salivary Carcinomas Localizes Subtype-Specific Chromosome Sites and Oncogenes of Potential Clinical Significance.
The American Journal of Pathology,
Vol. 182,
Issue. 6,
p.
2048.